132 Results

People

  1. Mao
    Mao
  2. Li
    Li
  3. Usmani
    Usmani
  4. Vickers
    Vickers
  5. Gonen
    Gonen
  6. Liou
    Liou
  7. Bao
    Bao
  8. D'Angelica
    D'Angelica
  9. Jarnagin
    Jarnagin
  10. Kingham
    Kingham

Groups

  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (32)
  3. Surgery (31)
  4. Population Sciences Research Program (30)
  5. Survivorship Research (26)
  6. Epidemiology and Biostatistics (23)
  7. Sloan Kettering Institute Postdocs (23)
  8. Hematologic Malignancies, Division of (16)
  9. Biostatistics Service (14)
  10. Center for Hematologic Malignancies (14)
  1. "comparative effectiveness"
Formats
  1. Journal Article (114)
  2. Review (9)
  3. Editorial (5)
  4. Correspondence (2)
  5. Research Letter (2)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (32)
  3. Surgery (31)
  4. Population Sciences Research Program (30)
  5. Survivorship Research (26)
  6. Epidemiology and Biostatistics (23)

More Groups

People
  1. Jun Mao (9)
  2. Andrew Vickers (5)
  3. Qing Li (5)
  4. Saad Usmani (5)
  5. Kevin Liou (4)
  6. Mithat Gonen (4)

More People

Years
  1. 2025 (4)
  2. 2024 (23)
  3. 2023 (21)
  4. 2022 (9)
  5. 2021 (5)
  6. 2020 (9)

More Years

Publications
  1. Blood (5)
  2. Journal of Vascular and Interventional Radiology (5)
  3. Journal of Clinical Oncology (4)
  4. Annals of Surgery (3)
  5. Blood Advances (3)
  6. Blood Cancer Journal (3)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. Elsevier Science, Inc. (19)
  3. Springer (9)
  4. Wiley Blackwell (9)
  5. American Society of Hematology (8)
  6. Lippincott Williams & Wilkins (8)

More Publishers

Results (132)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response
    Research Letter

    Akhtar, O. S.; Cao, B.; Wang, X.; Torka, P.; Al-Jumayli, M.; Locke, F. L.; Freeman, C. L.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • The contribution of microvascular free flaps and pedicled flaps to successful chest wall surgery
    Journal Article

    Vanstraelen, S.; Ali, B.; Bains, M. S.; Shahzad, F.; Allen, R. J. Jr; Matros, E.; Dycoco, J.; Adusumilli, P. S.; Bott, M. J.; Downey, R. J.; more...
    Journal of Thoracic and Cardiovascular Surgery (2023)

    Fulltext@MSK | Save
  • Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: Subgroup analysis of a randomized clinical trial
    Journal Article

    Bao, T.; Zhi, W. I.; Baser, R. E.; Li, Q. S.; Weitzman, M.; Gillespie, E. F.; Robson, M.; Mao, J. J.
    Breast Cancer Research and Treatment (2023)

    Fulltext@MSK | Save
  • Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Journal Article

    Roeker, L. E.; DerSarkissian, M.; Ryan, K.; Chen, Y.; Duh, M. S.; Wahlstrom, S. K.; Hakre, S.; Yu, L.; Guo, H.; Mato, A. R.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
    Journal Article

    Heumann, T.; Judkins, C.; Li, K.; Lim, S. J.; Hoare, J.; Parkinson, R.; Cao, H.; Zhang, T.; Gai, J.; Celiker, B.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Accelerating the evolution of immune-related enterocolitis management
    Editorial

    Faleck, D. M.; Dougan, M.; Tello, M.; Grossman, J. E.; Moss, A. C.; Postow, M. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
    Journal Article

    Krishnan, A.; Nooka, A. K.; Chari, A.; Garfall, A. L.; Martin, T. G.; Nair, S.; Lin, X.; Qi, K.; Londhe, A.; Pei, L.; more...
    Journal of Comparative Effectiveness Research (2023)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity: Analysis of axicabtagene ciloleucel versus standard of care in patients with relapsed/refractory large B cell lymphoma
    Journal Article

    Kersten, M. J.; Qiao, Y.; Shah, R.; Solem, C.; Snider, J. T.; To, C.; Cheng, P.; Spooner, C.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save